Chinese General Practice ›› 2022, Vol. 25 ›› Issue (15): 1863-1868.DOI: 10.12114/j.issn.1007-9572.2022.02.013
Special Issue: 内分泌代谢性疾病最新文章合辑
• Article • Previous Articles Next Articles
Received:
2021-10-25
Revised:
2022-01-09
Published:
2022-03-23
Online:
2022-04-07
Contact:
Xiangyun CHANG
About author:
通讯作者:
常向云
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.02.013
组别 | 例数 | 性别(男/女) | 年龄( | BMI( | SBP( | DBP( | FPG〔 | FA〔M(P25,P75),mmol/L〕 | FINS( | CpS( |
---|---|---|---|---|---|---|---|---|---|---|
健康对照组 | 22 | 11/11 | 53.9±5.0 | 24.2±2.1 | 132±19 | 77±11 | 4.86±0.50 | 1.51(1.38,1.63) | 78.73±38.54 | 0.94±0.32 |
T2DM组 | 21 | 12/9 | 54.9±6.1 | 25.1±2.9 | 130±16 | 81±8 | 9.21±2.40 | 2.77(2.21,3.20) | 60.79±36.19 | 0.86±0.35 |
检验统计量值 | 0.220a | -0.559 | -1.214 | 0.416 | -1.376 | -8.119 | -5.614b | 1.571 | 0.723 | |
P值 | 0.639 | 0.579 | 0.232 | 0.680 | 0.176 | <0.001 | <0.001 | 0.124 | 0.474 | |
组别 | HOMA-IR〔M(P25,P75)〕 | LDL-C( | HDL-C( | hsa_circ_0005414〔M(P25,P75)〕 | hsa_circ_0139634〔M(P25,P75)〕 | hsa_circ_0032491〔M(P25,P75)〕 | hsa_circ_0002922( | |||
健康对照组 | 2.31(1.14,2.95) | 2.79±0.51 | 1.26±0.28 | 1.159(0.647,1.456) | 1.025(0.698,2.050) | 1.173(0.622,1.490) | 1.108±0.497 | |||
T2DM组 | 2.76(1.72,5.61) | 2.77±0.66 | 1.30±0.22 | 0.046(0.023,0.081) | 0.445(0.229,0.669) | 5.395(3.837,9.310) | 3.200±2.054 | |||
检验统计量值 | -1.264b | 0.115 | -0.598 | -5.612b | -3.377b | -5.248b | -4.543 | |||
P值 | 0.206 | 0.909 | 0.553 | <0.001 | 0.001 | <0.001 | <0.001 |
Table 1 Comparison of general information,biochemical indicators and relative expression levels of four candidate circRNAs in T2DM Han Chinese and healthy Han Chinese
组别 | 例数 | 性别(男/女) | 年龄( | BMI( | SBP( | DBP( | FPG〔 | FA〔M(P25,P75),mmol/L〕 | FINS( | CpS( |
---|---|---|---|---|---|---|---|---|---|---|
健康对照组 | 22 | 11/11 | 53.9±5.0 | 24.2±2.1 | 132±19 | 77±11 | 4.86±0.50 | 1.51(1.38,1.63) | 78.73±38.54 | 0.94±0.32 |
T2DM组 | 21 | 12/9 | 54.9±6.1 | 25.1±2.9 | 130±16 | 81±8 | 9.21±2.40 | 2.77(2.21,3.20) | 60.79±36.19 | 0.86±0.35 |
检验统计量值 | 0.220a | -0.559 | -1.214 | 0.416 | -1.376 | -8.119 | -5.614b | 1.571 | 0.723 | |
P值 | 0.639 | 0.579 | 0.232 | 0.680 | 0.176 | <0.001 | <0.001 | 0.124 | 0.474 | |
组别 | HOMA-IR〔M(P25,P75)〕 | LDL-C( | HDL-C( | hsa_circ_0005414〔M(P25,P75)〕 | hsa_circ_0139634〔M(P25,P75)〕 | hsa_circ_0032491〔M(P25,P75)〕 | hsa_circ_0002922( | |||
健康对照组 | 2.31(1.14,2.95) | 2.79±0.51 | 1.26±0.28 | 1.159(0.647,1.456) | 1.025(0.698,2.050) | 1.173(0.622,1.490) | 1.108±0.497 | |||
T2DM组 | 2.76(1.72,5.61) | 2.77±0.66 | 1.30±0.22 | 0.046(0.023,0.081) | 0.445(0.229,0.669) | 5.395(3.837,9.310) | 3.200±2.054 | |||
检验统计量值 | -1.264b | 0.115 | -0.598 | -5.612b | -3.377b | -5.248b | -4.543 | |||
P值 | 0.206 | 0.909 | 0.553 | <0.001 | 0.001 | <0.001 | <0.001 |
因变量 | 自变量 | β | 95%CI | SE | β' | t值 | P值 |
---|---|---|---|---|---|---|---|
hsa_circ_0005414 | FPG | -0.171 | (-0.252,-0.090) | 0.040 | -0.554 | -4.262 | <0.001 |
hsa_circ_0139634 | FA | -0.438 | (-0.734,-0.142) | 0.147 | -0.423 | -2.987 | 0.005 |
hsa_circ_0032491 | FPG | 0.876 | (0.579,1.173) | 0.147 | 0.655 | 5.956 | <0.001 |
log2FINS | -1.023 | (-1.993,-0.053) | 0.480 | -0.234 | -2.132 | 0.039 | |
hsa_circ_0002922 | FPG | 0.281 | (0.096,0.465) | 0.091 | 0.433 | 3.074 | 0.004 |
Table 2 Multiple linear regression analysis of the association of four candidate circRNAs with glucose metabolism related indicators in Han Chinese
因变量 | 自变量 | β | 95%CI | SE | β' | t值 | P值 |
---|---|---|---|---|---|---|---|
hsa_circ_0005414 | FPG | -0.171 | (-0.252,-0.090) | 0.040 | -0.554 | -4.262 | <0.001 |
hsa_circ_0139634 | FA | -0.438 | (-0.734,-0.142) | 0.147 | -0.423 | -2.987 | 0.005 |
hsa_circ_0032491 | FPG | 0.876 | (0.579,1.173) | 0.147 | 0.655 | 5.956 | <0.001 |
log2FINS | -1.023 | (-1.993,-0.053) | 0.480 | -0.234 | -2.132 | 0.039 | |
hsa_circ_0002922 | FPG | 0.281 | (0.096,0.465) | 0.091 | 0.433 | 3.074 | 0.004 |
circRNAs | AUC | 95%CI | 截断值 | P值 | 灵敏度(%) | 特异度(%) | 差异倍数 |
---|---|---|---|---|---|---|---|
hsa_circ_0139634 | 0.199 | (0.059,0.339) | -0.90 | 0.001 | 100.0 | 0 | 0.495 |
hsa_circ_0032491 | 0.968 | (0.914,1.000) | 2.22 | <0.001 | 100.0 | 86.4 | 6.506 |
hsa_circ_0002922 | 0.844 | (0.720,0.968) | 2.05 | <0.001 | 66.7 | 95.5 | 3.200 |
Table 3 Analysis of the value of four candidate circRNAs for the diagnosis of T2DM in Han Chinese
circRNAs | AUC | 95%CI | 截断值 | P值 | 灵敏度(%) | 特异度(%) | 差异倍数 |
---|---|---|---|---|---|---|---|
hsa_circ_0139634 | 0.199 | (0.059,0.339) | -0.90 | 0.001 | 100.0 | 0 | 0.495 |
hsa_circ_0032491 | 0.968 | (0.914,1.000) | 2.22 | <0.001 | 100.0 | 86.4 | 6.506 |
hsa_circ_0002922 | 0.844 | (0.720,0.968) | 2.05 | <0.001 | 66.7 | 95.5 | 3.200 |
因素 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
hsa_circ_0139634 | -2.384 | 0.883 | 7.298 | 0.007 | 0.092(0.016,0.520) |
hsa_circ_0032491 | 1.283 | 0.407 | 9.948 | 0.002 | 3.607(1.625,8.004) |
hsa_circ_0002922 | 1.630 | 0.566 | 8.295 | 0.004 | 5.105(1.683,15.482) |
Table 4 Univariate Logistic regression analysis of the association of three candidate circRNAs with T2DM in Han Chinese
因素 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
hsa_circ_0139634 | -2.384 | 0.883 | 7.298 | 0.007 | 0.092(0.016,0.520) |
hsa_circ_0032491 | 1.283 | 0.407 | 9.948 | 0.002 | 3.607(1.625,8.004) |
hsa_circ_0002922 | 1.630 | 0.566 | 8.295 | 0.004 | 5.105(1.683,15.482) |
[1] |
|
[2] | |
[3] |
|
[4] |
乔晓玲,郗光霞. 遗传学因素对2型糖尿病第一时相胰岛素分泌的影响[J]. 国际内分泌代谢杂志,2021,41(3):216-219.
|
[5] |
李智明,闻智鸣. 表观遗传学、环境与2型糖尿病之间的关系[J]. 医学研究杂志,2014,43(7):10-11,83.
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
仝梦维,常向云.新疆维吾尔族T2DM患者外周血circRNA差异表达初步研究[J]. 安徽医科大学学报,2022,57(1):41-46. DOI:10.19405/j.cnki.issn1000-1492.2022.01.009.
|
[12] |
World Health Organization. Definition,diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes[R]. Geneva:World Health Organization,1999.
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
王思思,李嘉江慧,董晶,等. 2型糖尿病相关环状RNA的筛选与验证研究[J]. 中国糖尿病杂志,2019,27(2):86-90. DOI:10.3969/j.issn.1006-6187.2019.02.002.
|
[18] |
徐文超,刘建平,狄静,等. 2型糖尿病患者外周血环状RNA差异表达分析[J]. 中国糖尿病杂志,2020,28(12):881-886. DOI:10.3969/j.issn.1006-6187.2020.12.001.
|
[19] |
|
[20] |
宁利俐,燕艳,付希英,等. 成人隐匿性自身免疫性糖尿病患者环状RNA差异性表达分析[J]. 中国糖尿病杂志,2020,28(8):561-567. DOI:10.3969/j.issn.1006-6187.2020.08.001.
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[1] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
[2] | LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778. |
[3] | LI Hao, LI Peijin, LIU Tingting, CUI Yiyuan, LI Sicong, LIU Lixing, FENG Li, Working Group on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment Guidelines for Cancer Pain. Guidelines on the Diagnosis and Treatment of Cancer Pain by Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2025, 28(30): 3729-3740. |
[4] | SHAO Xiaoying, SHAO Jie, ZHU Yan, SHAO Jinling, SHANG Ling, WU Zhenlian, ZHAO Yu, ZHANG Jiacai. Analysis of the Current Status of Iron Deficiency and Factors Affecting Iron Deficiency Anemia among Children Aged 6-36 Months in Guizhou Province [J]. Chinese General Practice, 2025, 28(27): 3368-3374. |
[5] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
[6] | YIN Jiahui, YANG Xinhui, WANG Jingjing, ZHANG Yajing, WANG Lijuan, FU Zuodi, KONG Xiangshuang, GUO Guangxia, LI Yufeng. Predictive Value Waist-to-height Ratio, Waist-to-hip Ratio and Body Mass Index for Metabolic Syndrome [J]. Chinese General Practice, 2025, 28(26): 3258-3263. |
[7] | ZHI Congcong, LI Xue, CHENG Yicheng, WANG Xiaolong, ZHENG Lihua. Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Hemorrhoids (2025 Edition) [J]. Chinese General Practice, 2025, 28(26): 3217-3228. |
[8] | PAN Qi, REN Jingjing, MA Fanghui, HU Mengjie. Survey of General Practitioners' Cognition and Needs for AI Assisted Diagnosis and Treatment Systems [J]. Chinese General Practice, 2025, 28(25): 3127-3136. |
[9] | LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999. |
[10] | ZHOU Qian, WU Xiaomin, WANG Baohua, YAN Ruohan, YU Miao, WU Jing. Study on Nomogram Prediction Model for Risk of Gastric Cancer [J]. Chinese General Practice, 2025, 28(23): 2870-2877. |
[11] | Chinese Geriatrics Society, General Practice Branch of Zhejiang Medical Association, the Expert Collaboration Group on Medically Unspecified Disease in General Practice. Expert Consensus on the Diagnosis, Treatment, and Management of Emaciation (2025) [J]. Chinese General Practice, 2025, 28(21): 2577-2594. |
[12] | GUO Shengteng, ZHANG Fenfen, WAN Di, YU Dongmei, WANG Qinghua. Risk Factors for Severe Acute Pancreatitis Complicated with Acute Lung Injury: a Meta-analysis [J]. Chinese General Practice, 2025, 28(20): 2546-2554. |
[13] | LIU Hongya, YU Dehua. Construction and Practice of Clinical Diagnosis and Treatment Technology Combining General Practice and Specialist in Shanghai Community [J]. Chinese General Practice, 2025, 28(19): 2390-2397. |
[14] | BIAN Ying, YIN Gang, ZHANG Zixun, TAO Hongbing. The Mechanism of Information Construction Enabling High-quality Development of Compact County-level Medical Consortium [J]. Chinese General Practice, 2025, 28(19): 2426-2432. |
[15] | DENG Yaqian, CAO Chunli, MA Jinmei, LI Wenxiao, XU Zelin, CHENG Jing, LI Jun. Predictive Value of S-Detect Combined with Virtual Touch Tissue Imaging Quantification in Axillary Lymph Node Metastasis of Breast Cancer [J]. Chinese General Practice, 2025, 28(17): 2149-2155. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||